You are required to be logged in to access the full website
Click here if you have forgotten your username or password
11 February 2026 - Investment company IP Group plc (LSE: IPO) announced on Wednesday that its portfolio company Microbiotica Ltd has reported positive results from its Phase 1b first-in-human COMPOSER-1 trial of MB310 in patients with ulcerative coli...
11 February 2026 - Dermatology specialist Galderma (SWX:GALD) announced on Wednesday the launch of Restylane Defyne and Restylane Refyne in Japan, marking the first approval and commercialisation of Optimal Balance Technology (OBT) hyaluronic acid in...
11 February 2026 - Artificial heart technology company Scandinavian Real Heart AB (Nasdaq Stockholm First North Growth Market:HEART) announced on Wednesday that it has received patent approval from the European Patent Office for its Realheart TAH (To...
11 February 2026 - Aptamer Group plc (AIM: APTA) announced on Wednesday that Twist Bioscience Corporation has launched its TrueAmp Library Preparation Kit incorporating Aptamer's proprietary Optimer binders to enable room-temperature stability w...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe